StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
13
Publishing Date
2023 - 12 - 08
1
2023 - 08 - 16
1
2023 - 06 - 21
1
2023 - 04 - 24
1
2022 - 12 - 19
1
2022 - 08 - 17
2
2022 - 06 - 10
1
2022 - 06 - 07
1
2022 - 01 - 18
1
2021 - 11 - 22
1
2021 - 09 - 21
1
2021 - 06 - 07
1
Sector
Health technology
13
Tags
Acute myeloid leukemia
1
Agreement
1
Alliances
1
Aml
1
Application
3
Approval
4
Biotech-beach
2
Biotechnology
4
Blood
6
Blue
5
Car-t
3
Cardio
1
Cardiovascular
1
Cel
8
Cell
8
Chmp
1
Clinical hold
3
Clinical-trials-phase-ii
3
Collaboration
1
Commercial
5
Commercialization
1
Companies
1
Conference
6
Decades
1
Device
1
Disease
13
Drug
2
Earnings
6
Events
10
Fda
13
Fda-approvals
4
Financial
11
Financial results
7
Gene therapies
12
Gene therapy
14
Genetown
20
Global
3
Health
2
Ipo
6
License
4
Market
7
N/a
38
Offering
3
People
10
Pharm-country
2
Phase 2
2
Positive
2
Presentation
2
Program
2
Report
3
Research
8
Results
18
Review
3
T-cell
3
Therapeutics
5
Therapy
32
Trial
2
Update
3
Year
2
Zynteglo
2
Entities
22nd century group, inc
10
Abbott laboratories
80
Abbvie inc.
42
Acer therapeutics inc.
12
Adma biologics inc
18
Amgen inc.
23
Amneal pharmaceuticals, inc.
16
Ani pharmaceuticals, inc.
17
Apyx medical corporation
12
Aquestive therapeutics, inc.
15
Ardelyx, inc.
11
Arrival
10
Astellas pharma inc
17
Avenue therapeutics, inc.
10
Becton, dickinson and company
13
Beigene, ltd.
16
Biogen inc.
32
Biomarin pharmaceutical inc.
10
Biontech se
24
Bluebird bio, inc.
13
Boston scientific corporation
11
Brainstorm cell therapeutics inc.
14
Bristol-myers squibb company
20
Coherus biosciences, inc.
23
Eagle pharmaceuticals, inc.
11
Eli lilly and company
71
Eyenovia, inc.
13
Fortress biotech, inc.
14
Gilead sciences, inc.
21
Glaxosmithkline plc
14
Incyte corporation
23
Inhibikase therapeutics, inc.
10
Ionis pharmaceuticals, inc.
13
Jaguar health, inc.
16
Johnson & johnson
229
Medtronic plc
28
Merck & company, inc.
36
Mesoblast limited
15
Moderna, inc.
13
Novartis ag
29
Novavax, inc.
11
Novo nordisk a/s
11
Ocugen, inc.
15
Orange
63
Perrigo company
91
Pfizer, inc.
74
Reata pharmaceuticals, inc.
12
Regeneron pharmaceuticals, inc.
50
Sanofi
237
Seagen inc.
10
Soligenix, inc.
14
Sorrento therapeutics, inc.
21
T2 biosystems, inc.
14
Takeda pharmaceutical company limited
17
Teva pharmaceutical industries ltd
22
Thermo fisher scientific inc
16
Tonix pharmaceuticals holding corp.
12
Verrica pharmaceuticals inc.
13
Vertex pharmaceuticals incorporated
14
Veru inc.
14
Symbols
BLUE
13
Exchanges
Nasdaq
13
Crawled Date
2023 - 12 - 08
1
2023 - 08 - 16
1
2023 - 06 - 21
1
2023 - 04 - 24
1
2022 - 12 - 19
1
2022 - 08 - 17
2
2022 - 06 - 10
1
2022 - 06 - 07
1
2022 - 01 - 18
1
2021 - 11 - 22
1
2021 - 09 - 22
1
2021 - 06 - 07
1
Crawled Time
01:00
1
12:00
2
12:30
1
13:00
3
13:20
1
14:30
1
18:00
1
22:00
3
Source
www.biospace.com
12
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Fda
entities :
Bluebird bio, inc.
save search
bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
Published:
2023-12-08
(Crawled : 22:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-79.83%
|
O:
6.03%
H:
8.43%
C:
-43.92%
fda
disease
approval
cell
bluebird bio Confirms That FDA Has Communicated That Advisory Committee Meeting Will Not Be Scheduled for lovo-cel Gene Therapy for Sickle Cell Disease
Published:
2023-08-16
(Crawled : 13:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-73.2%
|
O:
-1.66%
H:
2.81%
C:
0.28%
fda
disease
cell
meeting
therapy
bluebird bio Announces FDA Priority Review of the Biologics License Application for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusive Events
Published:
2023-06-21
(Crawled : 12:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-72.36%
|
O:
0.85%
H:
1.13%
C:
-3.39%
fda
disease
license
review
cell
application
bluebird bio Submits Biologics License Application (BLA) to FDA for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusive Events
Published:
2023-04-24
(Crawled : 12:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-71.72%
|
O:
9.04%
H:
0.27%
C:
-8.02%
fda
disease
license
cell
application
FDA Lifts Partial Clinical Hold for bluebird bio’s Sickle Cell Disease (SCD) Studies for Patients Under the Age of 18
Published:
2022-12-19
(Crawled : 13:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-87.4%
|
O:
0.0%
H:
1.23%
C:
-6.75%
fda
disease
clinical hold
bluebird bio Announces FDA Approval of ZYNTEGLO®, the First Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusions
Published:
2022-08-17
(Crawled : 22:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-85.26%
|
O:
-4.41%
H:
30.05%
C:
7.79%
zynteglo
fda
blood
approval
therapy
FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions
Published:
2022-08-17
(Crawled : 18:00)
- prnewswire.com
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-85.26%
|
O:
-4.41%
H:
30.05%
C:
7.79%
fda
blood
therapy
FDA Advisory Committee Unanimously Supports beti-cel Gene Therapy for People with beta-thalassemia Who Require Regular Red Blood Cell Transfusions
Published:
2022-06-10
(Crawled : 22:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
Email alert
Add to watchlist
fda
blood
therapy
bluebird bio Announces Posting of Briefing Documents for Upcoming FDA Advisory Committee Meeting
Published:
2022-06-07
(Crawled : 13:20)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-67.45%
|
O:
-1.01%
H:
22.68%
C:
22.37%
fda
bluebird Provides Update on FDA Review Timelines for Betibeglogene Autotemcel (beti-cel) for Beta-Thalassemia and Elivaldogene Autotemcel (eli-cel) for Cerebral Adrenoleukodystrophy (CALD)
Published:
2022-01-18
(Crawled : 12:30)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-88.95%
|
O:
-3.19%
H:
1.0%
C:
-6.94%
fda
cel
bluebird bio Announces FDA Priority Review of Biologics License Application for beti-cel Gene Therapy for Patients with β-thalassemia Who Require Regular Red Blood Cell Transfusions
Published:
2021-11-22
(Crawled : 14:30)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-90.93%
|
O:
5.7%
H:
0.44%
C:
-6.81%
fda
blood
transfusion
application
gene therapy
therapy
license
cel
bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood Cell Transfusions
Published:
2021-09-21
(Crawled : 01:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-94.6%
|
O:
0.0%
H:
1.56%
C:
0.11%
fda
blood
gene therapy
therapy
license
gene therapies
cel
bluebird bio Announces the Lifting of FDA Clinical Hold for Sickle Cell Disease and β-Thalassemia Studies
Published:
2021-06-07
(Crawled : 13:00)
- biospace.com/
BLUE
|
$0.9274
-4.45%
-4.66%
8.1M
|
Health Technology
|
-96.86%
|
O:
4.85%
H:
0.46%
C:
-1.36%
disease
fda
clinical hold
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.